ketorolac has been researched along with Cranial Nerve II Injuries in 2 studies
Ketorolac: A pyrrolizine carboxylic acid derivative structurally related to INDOMETHACIN. It is an NSAID and is used principally for its analgesic activity. (From Martindale The Extra Pharmacopoeia, 31st ed)
ketorolac : A racemate comprising equimolar amounts of (R)-(+)- and (S)-(-)-5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid. While only the (S)-(-) enantiomer is a COX1 and COX2 inhibitor, the (R)-(+) enantiomer exhibits potent analgesic activity. A non-steroidal anti-inflammatory drug, ketorolac is mainly used (generally as the tromethamine salt) for its potent analgesic properties in the short-term management of post-operative pain, and in eye drops to relieve the ocular itching associated with seasonal allergic conjunctivitis. It was withdrawn from the market in many countries in 1993 following association with haemorrhage and renal failure.
5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid : A member of the class of pyrrolizines that is 2,3-dihydro-1H-pyrrolizine which is substituted at positions 1 and 5 by carboxy and benzoyl groups, respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ketorolac treatments were administered either 1 week before optic nerve crush (pre-ONC) or right after the ONC (simultaneous)." | 1.43 | Ketorolac Administration Attenuates Retinal Ganglion Cell Death After Axonal Injury. ( Agudo-Barriuso, M; Bravo-Osuna, I; Herrero-Vanrell, R; Molina-Martínez, I; Nadal-Nicolás, FM; Rodriguez-Villagra, E; Sobrado-Calvo, P; Vidal-Sanz, M; Villegas-Pérez, MP, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nadal-Nicolás, FM | 1 |
| Rodriguez-Villagra, E | 1 |
| Bravo-Osuna, I | 1 |
| Sobrado-Calvo, P | 1 |
| Molina-Martínez, I | 1 |
| Villegas-Pérez, MP | 1 |
| Vidal-Sanz, M | 1 |
| Agudo-Barriuso, M | 1 |
| Herrero-Vanrell, R | 1 |
| Tandon, R | 1 |
| Vanathi, M | 1 |
| Verma, L | 1 |
| Bharadwaj, A | 1 |
2 other studies available for ketorolac and Cranial Nerve II Injuries
| Article | Year |
|---|---|
Ketorolac Administration Attenuates Retinal Ganglion Cell Death After Axonal Injury.
Topics: Animals; Axons; Axotomy; Cell Survival; Cyclooxygenase Inhibitors; Disease Models, Animal; Female; K | 2016 |
Central serous retinopathy masquerading as sympathetic ophthalmia.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Diagnosis, Differential; Eye Injuries, Penetrating; | 2003 |